The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients
Official Title: Metaxa's Thromboprophylaxis Program in Oncological & Surgical Patients
Study ID: NCT04248348
Brief Summary: During MeTHOS study will be collected Real World Data the clinical practice regarding Thromboprophylaxis in high thrombotic risk solid tumors patients undergoing surgical and /or chemotherapeutical treatment, for one year following the protocol initiation date. Specifically focus will be on the following: * Number of thrombotic events * Anti-thrombotic management dosage \& duration * Any bleedings related to anticoagulation * Patients' adherence and compliance
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Metaxa Hopital, Piraeus, Attica, Greece
Name: Nikos Ziras, MD
Affiliation: Metaxa Hospital
Role: STUDY_CHAIR
Name: Spyridon Xynogalos, MD
Affiliation: Metaxa Hospital
Role: PRINCIPAL_INVESTIGATOR